Drostanolone Enanthate
Drostanolone Enanthate
Drostanolone Enanthate EXP 02/28 Batch DP3052V
200MG/ML
Masteron is indicated for treatment of breast cancer in elderly post-menopausal as part of aspecific immunotherapy.
Drostanolone, or dromostanolone, is an anabolic–androgenic steroid (AAS) of the dihydrotestosterone (DHT) group which was never marketed. An androgen ester prodrug of drostanolone, drostanolone Enanthate, was formerly used in the treatment of breast cancer in women under brand names such as Drolban, Masteril, and Masteron. This ester has also been used non-medically for physique- or performance-enhancing purposes.
Masteron or Drostanolone Enanthate is a dihydrotestosterone derived anabolic steroid. Specifically, Masteron is the hormone that has been structurally altered by the addition of a methyl group at the carbon 2 position, This protects the hormone from the metabolic breakdown by the 3-hydroxysteroid dehydrogenase enzyme, which is found in the skeletal muscle. It also greatly increases the hormone’s anabolic nature. This simple structural change is all it takes to create Drostanolone, and from here the small/short Enanthate ester is attached in order to control the hormone’s release time.
Drostanolone Enanthate can also be found through some underground labs, which does not have to be injected as frequently, but it is somewhat rare compared to the Propionate version. The majority of all Masteron on the market will be Drostanolone Enanthate. On a functional basis, Masteron is well-known for being one of the only anabolic steroids with strong anti-estrogenic properties. Not only does this steroid carry no estrogenic activity, but it can actually act as an anti-estrogen in the body. This is why it has been effective in the treatment of breast cancer. In fact, the combination of Masteron and Nolvadex (Tamoxifen Citrate) has been shown to be far more effective than chemotherapy in the treatment of inoperable breast cancer in postmenopausal women.